apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

The tanning habits and interest in sunscreen of Google users: what happened in 12 years? (2017) Kirchberger MC, Heppt MV, Eigentler TK, Kirchberger MA, Schuler G, Heinzerling L Journal article Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein (2017) Buschow SI, Ramazzotti M, Reinieren-Beeren IMJ, Heinzerling L, Westdorp H, Stefanini I, Beltrame L, et al. Journal article Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition (2017) Heppt MV, Heinzerling L, Kaehler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, et al. Journal article Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma (2017) Heppt MV, Roesch A, Weide B, Gutzmer R, Meier F, Loquai C, Kaehler KC, et al. Journal article Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity (2017) Gutzmer R, Koop A, Meier F, Hassel JC, Terheyden P, Zimmer L, Heinzerling L, et al. Journal article The neurotrophin Neuritin1 (cpg15) is involved in melanoma migration, attachment independent growth, and vascular mimicry (2017) Boßerhoff AK, Schneider N, Ellmann L, Heinzerling L, Kuphal S Journal article Predicting the response to anti-PD1 therapy in metastatic melanoma (2016) Heinzerling L, Kirchberger MC, Walter L, Schuler G Journal article, Letter Outcome on 560 metastatic melanoma (MM) patients treated with pembrolizumab during the German Expanded Access Program (EAP) (2016) Hassel J, Forschner A, Bluhm L, Heinzerling L, Zimmer L, Utikal J, Kaehler K, et al. Conference contribution Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab (2016) Weide B, Martens A, Hassel JC, Berking C, Postow MA, Bisschop K, Simeone E, et al. Journal article Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy (2016) Heinzerling L, Ott PA, Hodi FS, Husain AN, Tajmir-Riahi A, Tawbi H, Pauschinger M, et al. Journal article